Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia

Circulation: Cardiovascular Genetics

Volumn 7, Issue 6, 2014, Pages 814-821

  De Castro Orós, Isabel ^a   Cenarro, Ana ^a   Tejedor, María Teresa ^b   Baila Rueda, Lucía ^a   Mateo Gallego, Rocío ^a   Lamiquiz Moneo, Itziar ^a   Pocoví, Miguel ^b   Civeira, Fernando ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

APOA5 protein; Familial combined; Human; Hyperlipidemia; Hypertriglyceridemia

Indexed keywords

ADIPONECTIN RECEPTOR 2; APOLIPOPROTEIN A5; APOLIPOPROTEIN E; CHOLESTEROL 7ALPHA MONOOXYGENASE; GLUCOSE; INTERLEUKIN 6; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; GCKR PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; LPL PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ANGPTL3 GENE; ARTICLE; BODY MASS; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; GALNTN2 GENE; GCKR GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTRIGLYCERIDEMIA; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; TRIB1 GENE; AGE; ALLELE; ANALYSIS; BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE FACTORS; ALLELES; APOLIPOPROTEINS A; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; TRIGLYCERIDES;

EID: 84925844427     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000522     Document Type: Article

References (33)

1. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 2009;169:572-578
2. Casasnovas JA, Alcaide V, Civeira F, Guallar E, Ibañez B, Borreguero JJ, et al. Aragon workers' health study-design and cohort description. BMC Cardiovasc Disord. 2012;12:45
3. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS Ricketts SL, Butterworth AS, Di Angelantonio E, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010;375:1634-1639
4. Murad MH, Hazem A, Coto-Yglesias F, Dzyubak S, Gupta S, Bancos I, Lane MA, et al. The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis. BMC Endocr Disord. 2012;12:2
5. Hjellvik V, Sakshaug S, Strøm H. Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin Epidemiol. 2012;4:213-224
6. Joseph J, Svartberg J, Njølstad I, Schirmer H. Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study. Scand J Public Health. 2010;38:768-775
7. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993-2000
8. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al.; Endocrine Society. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2969-2989
9. Solanas-Barca M, de Castro-Orós I, Mateo-Gallego R, Cofán M, Plana N, Puzo J, Burillo E, et al. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia. Atherosclerosis. 2012;222:449-455
10. Brunzell JD. Clinical practice. Hypertriglyceridemia. N Engl J Med. 2007;357:1009-1017
11. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003;108:519-523
12. Willer CJ, Mohlke KL. Finding genes and variants for lipid levels after genome-wide association analysis. Curr Opin Lipidol. 2012;23: 98-103
13. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713
14. Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45:1345-1352
15. Johansen CT, Hegele RA. Allelic and phenotypic spectrum of plasma triglycerides. Biochim Biophys Acta. 2012;1821:833-842
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421
17. Gómez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, Porres A, Rueda A, Avellaneda A, et al. Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group. Med Clin (Barc). 1999;113:730-735
18. Solanas-Barca M, Mateo-Gallego R, Calmarza P, Jarauta E, Bea AM, Cenarro A, et al. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia. J Clin Endocrinol Metab. 2009;94:4391-4397
19. Jarauta E, Mateo-Gallego R, Bea A, Burillo E, Calmarza P, Civeira F. Carotid intima-media thickness in subjects with no cardiovascular risk factors. Rev Esp Cardiol. 2010;63:97-102
20. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 2002;3:146-153
21. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996;86:726-728
22. The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65
23. Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet. 2010;42:684-687
24. Brouwers MC, van Greevenbroek MM, Stehouwer CD, de Graaf J, Stalenhoef AF. The genetics of familial combined hyperlipidaemia. Nat Rev Endocrinol. 2012;8:352-362
25. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 2008;414:1-18
26. Global Lipids Genetics Consortium, Willer CJ, Schmidt EM et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274-1283
27. Plaisier CL, Horvacth S, Huertas-Vazquz A, et al. A systems Genetics Approach Implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Gen. 2009;5:e1000642
28. Sagos GS, Tatt I, Salanti G, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: A HuGE Association Review and Meta-Analysis. Am J Epidemiol. 2008;168:1233-1246
29. Johansen CT, Wang J, Lanktree MB, et al. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2011;31:1916-1926
30. Johansen CT, Hegele RA. The complex genetic basis of plasma triglycerides. Curr Atheroscler Rep. 2012;14:227-234
31. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169-173
32. Nilsson SK, Heeren J, Olivecrona G, Merkel M. Apolipoprotein A-V; a potent triglyceride reducer. Atherosclerosis. 2011;219:15-21
33. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet. 2009;18:4081-4088.